GC CELL
GC Cell, founded to specialize in cell therapy, obtained approval for its developed Immunecell-LC as a liver cancer immunotherapy agent in 2007. Immunecell-LC has now finished third-phase clinical trials on liver cancer and brain tumors (glioblastoma/GBM), and is tailed by studies, published in SCI-level journals, on its efficacy in treating liver cancer, brain tumors, and pancreatic cancer (researcher-conducted clinical trial). The company is now researching and developing CAR-T, a next-generation cell immunotherapy agent, and, in partnership with ToolGen, a T-cell-based next-generation cancer immunotherapy agent with greater performance.
GC CELL
Industry:
Biotechnology Life Science Therapeutics
Founded:
2002-01-01
Address:
Yongin, Ch'ungch'ong-namdo, South Korea
Country:
South Korea
Website Url:
http://www.m.globalgreencross.com
Status:
Active
Contact:
+82-31-736-6700
Technology used in webpage:
IPhone / Mobile Compatible Apache Amazon Amazon Route 53 Java EE Apache Tomcat Coyote Amazon South Korea Region
Similar Organizations
Rebirthel
Rebirthel is a biotech company, focused on the Development and operationalization of cell-based cancer immunotherapies.
Stock Details
Official Site Inspections
http://www.m.globalgreencross.com
- Host name: ec2-13-124-105-207.ap-northeast-2.compute.amazonaws.com
- IP address: 13.124.105.207
- Location: Incheon South Korea
- Latitude: 37.4562
- Longitude: 126.7288
- Timezone: Asia/Seoul
- Postal: 21539
